Controversial Therapies for Autism and Intellectual Disabilities 2nd Edition Fad, Fashion, and Science in Professional Practice – James A. Mulick, Richard M. Foxx

SKU : PRE-9781138802230

$34.65

CAUTION: You’re about to purchase a high quality copy (no missing contents), NOT a Paper Book! It can be printed, stored and read on any devices. You’ll get this copy via EMAIL within 24 after purchasing.

Controversial Therapies for Autism and Intellectual Disabilities, 2nd Edition, delves into the complex world of treatments for autism and intellectual disabilities, examining those considered controversial. Authors James A. Mulick and Richard M. Foxx critically analyze various approaches, separating fad and fashion from scientifically sound practices.

This insightful text explores a range of therapies, providing a balanced perspective on their effectiveness and potential risks. It equips professionals with the knowledge needed to make informed decisions about treatment options for their patients. The book emphasizes evidence-based practice and the importance of critical evaluation in the field.

By examining the historical context and current trends, the authors provide readers with a comprehensive understanding of the challenges and successes in developing effective interventions. This second edition reflects the latest research and advancements in the field, offering an updated and relevant resource for professionals working with individuals with autism and intellectual disabilities.

The book serves as a valuable resource for clinicians, researchers, educators, and anyone interested in understanding the complexities of autism and intellectual disability treatment. It encourages a critical appraisal of therapeutic interventions, promoting a responsible and ethical approach to professional practice.

Controversial Therapies for Autism & Intellectual Disabilities, 2nd ed. (ISBN: 9781138802230) by James A. Mulick & Richard M. Foxx. Critically analyzes controversial treatments, separating fad from science-based practices. Essential for clinicians & researchers.